Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04197999
Recruitment Status : Recruiting
First Posted : December 13, 2019
Last Update Posted : April 1, 2021
Sponsor:
Information provided by (Responsible Party):
GlycoMimetics Incorporated

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : March 2022